Topiramate antagonizes NMDA- and AMPA-induced seizure-like activity in planarians

Pharmacology Biochemistry and Behavior

Volumn 93, Issue 4, 2009, Pages 363-367

  Rawls, Scott M ^a   Thomas, Timmy ^a   Adeola, Mobilaji ^a   Patil, Tanvi ^a   Raymondi, Natalie ^a   Poles, Asha ^a   Loo, Michael ^a   Raffa, Robert B ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AMPA; Glutamate receptors; MK 801; NMDA; Planarians; Topiramate

Indexed keywords

6,7 DINITRO 2,3 QUINOXALINEDIONE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR ANTAGONIST; DIZOCILPINE; GLUTAMATE RECEPTOR; GLYCINE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROTRANSMITTER; TOPIRAMATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EXPOSURE; INHIBITION KINETICS; NONHUMAN; PHARMACOLOGICAL BLOCKING; PLATYHELMINTH; PRIORITY JOURNAL; PROTEIN FUNCTION; SEIZURE; TURBELLARIA;

ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; BEHAVIOR, ANIMAL; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; FRUCTOSE; N-METHYLASPARTATE; NEUROPROTECTIVE AGENTS; PLANARIANS; QUINOXALINES; SEIZURES;

INVERTEBRATA; MAMMALIA; PLANARIA; PLATYHELMINTHES; TURBELLARIA;

EID: 67849114042     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2009.05.005     Document Type: Article

References (45)

1. Angehagen M., Ben-Menachem E., Shank R., Ronnback L., and Hansson E. Topiramate modulation of kainate-induced calcium currents is inversely related to channel phosphorylation level. J Neurochem 88 (2004) 320-325
2. 2+ transients and inhibits GluR1 subunit phosphorylation in astrocytes from primary cultures. J Neurochem 94 (2005) 1124-1130
3. Bazan N.G., Tu B., and Rodriguez de Turco E.B. What synaptic lipid signaling tells us about seizure-induced damage and epileptogenesis. Prog Brain Res 135 (2002) 175-185
4. Cebrià F., Kudome T., Nakazawa M., Mineta K., Ikeo K., Gojobori T., et al. The expression of neural-specific genes reveals the structural and molecular complexity of the planarian central nervous system. Mech Dev 116 (2002) 199-204
5. Curia G., Aracri P., Sancini G., Mantegazza M., Avanzini G., and Franceschetti S. Protein-kinase C-dependent phosphorylation inhibits the effect of the antiepileptic drug topiramate on the persistent fraction of sodium currents. Neuroscience 127 (2004) 63-68
6. DeLorenzo R.J., Sombati S., and Coulter D.A. Effects of topiramate on sustained repetitive fi{ligature}ring and spontaneous recurrent seizure discharges in cultured hippocampal neurons. Epilepsia 41 Suppl.1 (2000) S40-S44
7. Dodgson S.J., Shank R.P., and Maryanoff B.E. Topiramate as an inhibitor of carbonic anhydrase isozymes. Epilepsia 41 Suppl.1 (2000) S35-S39
8. Du J., Creson T.K., Wu L.J., Ren M., Gray N.A., Falke C., et al. The role of hippocampal GluR1 and GluR2 receptors in manic-like behavior. J Neurosci 28 (2008) 68-79
9. Furuta A., Noda M., Suzuki S.O., Goto Y., Kanahori Y., Rothstein J.D., et al. Translocation of glutamate transporter subtype excitatory amino acid carrier 1 protein in kainic acid-induced rat epilepsy. Am J Pathol 163 (2003) 779-787
10. Gibbs III J.W., Sombati S., DeLorenzo R.J., and Coulter D.A. Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons. Epilepsia 41 Suppl.1 (2000) S10-S16
11. A receptors expressed in Xenopus oocytes to modulation by topiramate. Epilepsia 41 Suppl.1 (2000) S25-S29
12. Gryder D.S., and Rogawski M.A. Selective antagonism of GluR5 kainate-receptor-mediated synaptic currents by topiramate in rat basolateral amygdala neurons. J Neurosci 23 (2003) 7069-7074
13. A-mediated responses and activation of a potassium conductance. Neuropharmacology 42 (2002) 210-220
14. Kim M.J., Fytai K., Jo J., Hayashi Y., Cho K., and Sheng M. Synaptic accumulation of PSD-95 and synaptic function regulated by phosphorylation of serine-295 of PSD-95. Neuron 56 (2007) 488-502
15. Kuzmiski J.B., Barr W., Zamponi G.W., and MacVicar B.A. Topiramate inhibits the initiation of plateau potentials in CA1 neurons by depressing R-type calcium channels. Epilepsia 46 (2005) 481-489
16. Leppik I.E., Kelly K.M., deToledo-Morrell L., Patrylo P.R., DeLorenzo R.J., Mathern G.W., et al. Basic research in epilepsy and aging. Epilepsy Res 68S (2006) S21-37
17. Maryanoff B.E., Nortey S.O., Gardocki J.F., Shank R.P., and Dodgson S.P. Anticonvulsant O-alkyl sulfamates, 23:45-Bis-O-(1-methylethylidene)-β-D-fructopyranose sulfamate and related compounds. J Med Chem 30 (1987) 880-887
18. McLean M.J., Bukhari A.A., and Wamil A.W. Effects of topiramate on sodium-dependent action potential fi{ligature}ring by mouse spinal cord neurons in cell culture. Epilepsia 41 Suppl.1 (2000) S21-S24
19. 2+ channels by carbonic anhydrase inhibitors. J Pharmacol Sci 95 (2004) 240-247
20. Nakamura J., Kuwana Y., and Yukitoshi N. Target pharmacology of topiramate, a new antiepileptic drug. Nippon Yakurigaku Zasshi 115 (2000) 53-57
21. Okada M., Zhu G., Yoshida K., Kanaia K., Hirosec S., and Kanekoa S. Exocytosis mechanism as a new targeting site for mechanisms of action of antiepileptic drugs. Life Sci 72 (2005) 465-473
22. 2+-releasing systems. Neuroscience 134 (2005) 233-246
23. Pappalardo A., Liberto A., Patti F., and Reggio A. Neuroprotective effects of topiramate. Clin Ter 155 (2004) 75-78
24. Poulsen C.F., Simeone T.A., Maar T.E., Smith-Swintosky V., White H.S., and Schousboe A. Modulation by topiramate of AMPA and kainate mediated calcium infl{ligature}ux in cultured cerebral cortical, hippocampal and cerebellar neurons. Neurochem Res 29 (2004) 275-282 2004
25. Qian J., and Noebels J.L. Topiramate alters excitatory synaptic transmission in mouse hippocampus. Epilepsy Res 55 (2003) 225-233
26. Raffa R.B., and Rawls S.M. Planaria: A Model for Drug Action and Abuse (2008), Landes Bioscience, Austin TX
27. Rawls S.M., Gomez T., and Raffa R.B. An NMDA antagonist (LY 235959) attenuates abstinence-induced withdrawal of planarians following acute exposure to a cannabinoid agonist (WIN 55212-2). Pharmacol Biochem Behav 86 (2007) 499-504
28. Rawls S.M., Gomez T., Stagliano G.W., and Raffa R.B. Measurement of glutamate and aspartate in Planaria. J Pharmacol Toxicol Methods 53 (2006) 291-295
29. Russo E., and Constanti A. Topiramate hyperpolarizes and modulates the slow post-stimulus AHP of rat olfactory cortical neurones in vitro. Br J Pharmacol 141 (2004) 285-301
30. Shank R.P., and Maryanoff B.E. Molecular pharmacodynamics clinical therapeutics and pharmacokinetics of topiramate. CNS Neurosci Ther 14 (2008) 120-142
31. Shank R.P., Doose D.R., Streeter A.J., and Bialer M. Plasma and whole blood pharmacokinetics of topiramate: the role of carbonic anhydrase. Epilepsy Res 63 (2005) 103-112
32. Shank R.P., Gardocki J.F., Vaught J.L., Davis C.B., Schupsky J.J., Raffa R.B., et al. Topiramate: preclinical evaluation of a structurally novel anticonvulsant. Epilepsia 35 (1994) 450-460
33. Shank R.P., Gardocki J.F., Streeter A.J., and Maryanoff B.E. An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action. Epilepsia 41 Suppl 1 (2000) S3-S9 Review
34. Shank R.P., McComsey D.F., Smith-Swintosky V.L., and Maryanoff B.E. Examination of two independent kinetic assays for determining the inhibition of carbonic anhydrases I and II: structure-activity comparison of sulfamates and sulfamides. Chem Biol Drug Design 68 (2006) 113-119
35. A. Neuropharmacology 50 (2006) 845-857
36. Skradski S., and White H.S. Topiramate blocks kainate-evoked cobalt infl{ligature}ux into cultured neurons. Epilepsia 41 Suppl.1 (2000) S45-S47
37. v 1.3 α-subunit. Epilepsia 48 (2007) 774-782
38. + current fractions by the new anticonvulsant topiramate. J Pharmacol Exp Ther 288 (1999) 960-968
39. - currents. Epilepsia 36 Suppl. 3 (1995) S39-40
40. White H.S., Brown S.D., Woodhead J.H., Skeen G.A., and Wolf H.H. Topiramate enhances GABA-mediated chloride fl{ligature}ux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold. Epilepsy Res 28 (1997) 167-179
41. White H.S., Brown S.D., Woodhead J., Skeen G.A., and Wolf H.H. Topiramate modulates GABA-evoked currents in murine cortical neurons by a non-benzodiazepine mechanism. Epilepsia 41 Suppl.1 (2000) S17-20
42. Wu S.P., Tsai J.J., and Gean P.W. Frequency-dependent inhibition of neuronal fi{ligature}ring by topiramate in hippocampal slices. Brit J Pharmacol 125 (1999) 826-832
43. Zhang X.-L., Velumian A.A., Jones O.T., and Carlen P.L. Modulation of high-voltage-activated calcium channels in dentate granule cells by topiramate. Epilepsia 41 Suppl.1 (2000) S52-60
44. Ziemann U. Pharmacology of TMS. Suppl Clin Neurophysiol 56 (2003) 226-231
45. Zona C., Ciotti M.T., and Avoli M. Topiramate attenuates voltage-gated sodium currents in rat cerebellar granule cells in culture. Neurosci Lett 231 (1997) 123-126